adMare Bio Innovations

adMare Bio Innovations is a Vancouver-based, not-for-profit life sciences venture builder and accelerator that translates academic research into commercially viable therapeutics. The accelerator's portfolio of supported life sciences companies includes notable biotechnology firms such as Zymeworks, AbCellera, Bellus Health, and Inversago Pharma. Backed by $92 million in federal funding, the organization provides early-stage biotechnology startups with pre-seed investment, commercial research infrastructure, and intellectual property expertise to scale new enterprises. These supported ventures have collectively attracted over $2.5 billion in risk capital while creating approximately 1,000 industry jobs across the Canadian ecosystem, achieving a combined $5.8 billion portfolio valuation. Founded in 2019 by Gordon McCauley through the merger of the Centre for Drug Research and Development and the NEOMED Institute, the organization employs 132 professionals to advance precision medicine, rare diseases, and cancer therapies.